Research map: Optimization and formulation of cyclosporine-loaded nanostructured lipid carriers (NLCs) for the management of dry eye syndrome by using centre composite design approaches

Back to the article

Papers in this map

  1. TFOS DEWS II Definition and Classification Report · Jennifer P. Craig · 2017 · 3411 citations · Cited by this paper
  2. Global research trends in central retinal artery occlusion: a bibliometric analysis (1980–2025) · 2026 · Related
  3. Development of solid lipid nanoparticles and nanostructured lipid carriers for improving ocular delivery of acyclovir · Ali Seyfoddin · 2012 · 164 citations · Cited by this paper
  4. The effect of forced infusion in phacoemulsification training: a comparative study · 2026 · Related
  5. Current updated review on preparation of polymeric nanoparticles for drug delivery and biomedical applications · Harish Bhardwaj · 2023 · 164 citations · Cited by this paper
  6. Use of electronic health records to examine margin-to-reflex distance in patients without eyelid conditions affecting position · 2026 · Related
  7. Short Term Stability Testing of Efavirenz-Loaded Solid Lipid Nanoparticle (SLN) and Nanostructured Lipid Carrier (NLC) Dispersions · Pedzisai A. Makoni · 2019 · 156 citations · Cited by this paper
  8. Latitudinal variation in morphological patterns of lens opacity among patients with cataracts · 2026 · Related
  9. A new topical formulation for psoriasis: Development of methotrexate-loaded nanostructured lipid carriers · Maria Filipa Pinto · 2014 · 123 citations · Cited by this paper
  10. Assesment of oxidative stress and antioxidant status in pseudoexfoliation syndrome with ocular and systemic comorbidities · 2026 · Related
  11. Cyclosporine-A incorporated cationic solid lipid nanoparticles for ocular delivery · Ebru Başaran · 2010 · 113 citations · Cited by this paper
  12. Independent factors associated with ICL haptic position: a multivariate analysis of anterior and posterior segment parameters · 2026 · Related
  13. Challenges in Cyclosporine Therapy: The Role of Therapeutic Monitoring by Area Under the Curve Monitoring · Barry D. Kahan · 1995 · 108 citations · Cited by this paper
  14. Formulation development and preclinical assessment of ethyl acetate fraction of Saraca asoca (EASA) flowers for cataract management · 2026 · Related
  15. Recent advances in cyclosporine drug delivery: challenges and opportunities · Dhrumi Patel · 2019 · 78 citations · Cited by this paper
  16. Impact of rigid contact lens use on visual acuity and vision-related quality of life in keratoconus · 2026 · Related
  17. Enhanced Topical Delivery of Cyclosporin-A Using PLGA Nanoparticles as Carrier · Sanyog Jain · 2011 · 52 citations · Cited by this paper
  18. Evaluation of ocular surface retention of artificial tears by scintigraphy · 2026 · Related
  19. Dexamethasone-Loaded Nanostructured Lipid Carriers for the Treatment of Dry Eye Disease · Sangeeta Kumari · 2021 · 51 citations · Cited by this paper
  20. Nanostructured Lipid Carriers (NLC)-Based Topical Formulation of Hesperidin for Effective Treatment of Psoriasis · Anita Rani · 2025 · 40 citations · Cited by this paper
  21. Nanostructured Lipid Carriers to Enhance the Bioavailability and Solubility of Ranolazine: Statistical Optimization and Pharmacological Evaluations · Aziz Unnisa · 2023 · 38 citations · Cited by this paper
  22. Enhancement of oral bioavailability of cyclosporine A: comparison of various nanoscale drug-delivery systems · Jianping Qi · 2014 · 35 citations · Cited by this paper
  23. Lipid nanoparticles for cyclosporine A administration: development, characterization, and in vitro evaluation of their immunosuppression activity · María J. Blanco‐Prieto · 2015 · 32 citations · Cited by this paper
  24. Drug delivery strategies to improve the treatment of corneal disorders · Mahsa Fallah Tafti · 2025 · 27 citations · Cited by this paper
  25. A comprehensive review on possibilities of treating psoriasis using dermal cyclosporine · Sonia S. Pandey · 2021 · 26 citations · Cited by this paper
  26. Efficacy and Safety of Quantum Molecular Resonance Electrotherapy in Patients with Aqueous-Deficient, Evaporative and Mixed-Type Dry Eye: A Randomized Interventional Study · Antonio Ballesteros‐Sánchez · 2023 · 26 citations · Cited by this paper
  27. Prevalence of dry eye disease among children: a systematic review and meta-analysis · Yuhao Zou · 2025 · 26 citations · Cited by this paper
  28. Nanostructured lipid carrier based dermal gel of cyclosporine for atopic dermatitis-in vitro and in vivo evaluation · Sarika Wairkar · 2022 · 25 citations · Cited by this paper
  29. Opioids and Ocular Surface Pathology: A Literature Review of New Treatments Horizons · Celia García-López · 2022 · 20 citations · Cited by this paper
  30. The Influence of Lid-Parallel Conjunctival Folds and Conjunctivochalasis on Dry Eye Symptoms with and Without Contact Lens Wear: A Review of the Literature · Antonio Ballesteros‐Sánchez · 2024 · 20 citations · Cited by this paper
  31. Dry Eye Para-Inflammation Treatment: Evaluation of a Novel Tear Substitute Containing Hyaluronic Acid and Low-Dose Hydrocortisone · Davide Borroni · 2023 · 18 citations · Cited by this paper
  32. Quercetin loaded biogenic squalene nano-lipid carriers for the treatment of dry eye syndrome · Ajit Kumar Mishra · 2025 · 17 citations · Cited by this paper
  33. Evaluating GlicoPro Tear Substitute Derived from Helix aspersa Snail Mucus in Alleviating Severe Dry Eye Disease: A First-in-Human Study on Corneal Esthesiometry Recovery and Ocular Pain Relief · Antonio Ballesteros‐Sánchez · 2024 · 16 citations · Cited by this paper
  34. Decoding Allergic Conjunctivitis: Latest Perspectives on Etiological Drivers and Immunopathological Mechanisms · Jiayu Bao · 2025 · 13 citations · Cited by this paper
  35. Cyclosporine: Immunosuppressive effects, entwined toxicity, and clinical modulations of an organ transplant drug · Razan Alqadi · 2024 · 12 citations · Cited by this paper
  36. Augmented ocular uptake and anti-inflammatory efficacy of decorated Genistein-loaded NLCs incorporated in in situ gel · Marwa A Elmanawy · 2024 · 11 citations · Cited by this paper
  37. N-acetylcysteine and chitosan conjugate modified dexamethasone nanostructured lipid carriers: Enhanced permeability, precorneal retention and lower inflammation for the treatment of dry eye syndrome · Donghao Gu · 2025 · 11 citations · Cited by this paper
  38. Design and Development of Dasatinib Nanoemulsions for Ocular Delivery: In vitro Characterization, Biocompatibility, and Ex vivo Ocular Irritation Study · Richa Khadke · 2025 · 11 citations · Cited by this paper
  39. Cyclosporine a Eluting Nano Drug Reservoir Film for the Management of Dry Eye Disease · Pinal Chaudhari · 2025 · 11 citations · Cited by this paper

Source: OpenAlex (CC0)